Coloplast reaffirms FY2026 sales guidance at $4.499B
Coloplast (OTC: CLPBY) affirms FY2026 sales guidance of $4.499 billion versus a $4.420 billion estimate.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.